
    
      By enrolling patients with pancreatic cancer adapted to enrolled criteria, this study will
      document for the first time the safety and the short and long term efficacy of HepaSphere
      interventional therapy using digital subtraction Angiography（DSA）for pancreatic cancer.
    
  